Dosidal · Switzerland

Rizatriptan Sandoz, Schmelztabletten

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:63100 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 63100
atc: N02CC04
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2014-07-07
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: N02CC04
authorisation_number: 63100
form: SCHM
holder: Sandoz Pharmaceuticals AG
holder_partner_nr: 1006431
it_number: 02.05.1.
name: Rizatriptan Sandoz, Schmelztabletten
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
m798U8ETRob-MATGfcIB2LQ9i_tCshrs5NOPHEhjVZ3atnDbZ21aUMNHW8CvMbBToAcnZ6NqPboPEp9p6PojAA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:63100 · Related records in other markets · Dosidal